GB9701919D0 - Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1 - Google Patents

Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1

Info

Publication number
GB9701919D0
GB9701919D0 GBGB9701919.4A GB9701919A GB9701919D0 GB 9701919 D0 GB9701919 D0 GB 9701919D0 GB 9701919 A GB9701919 A GB 9701919A GB 9701919 D0 GB9701919 D0 GB 9701919D0
Authority
GB
United Kingdom
Prior art keywords
hiv
susceptibility
infection
diagnosis
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9701919.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB9701919.4A priority Critical patent/GB9701919D0/en
Priority to PCT/GB1997/000637 priority patent/WO1997032998A2/en
Priority to AU21019/97A priority patent/AU2101997A/en
Publication of GB9701919D0 publication Critical patent/GB9701919D0/en
Priority to PCT/GB1998/000300 priority patent/WO1998033938A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB9701919.4A 1996-03-08 1997-01-30 Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1 Pending GB9701919D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9701919.4A GB9701919D0 (en) 1997-01-30 1997-01-30 Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1
PCT/GB1997/000637 WO1997032998A2 (en) 1996-03-08 1997-03-10 Materials and methods relating to the identification of a polymorphism associated with disease susceptibility
AU21019/97A AU2101997A (en) 1996-03-08 1997-03-10 Materials and methods relating to the identification of a polymorphism associated with disease susceptibility
PCT/GB1998/000300 WO1998033938A1 (en) 1997-01-30 1998-01-30 Materials and methods relating to the identification of a polymorphism associated with disease susceptibility

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9701919.4A GB9701919D0 (en) 1997-01-30 1997-01-30 Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1

Publications (1)

Publication Number Publication Date
GB9701919D0 true GB9701919D0 (en) 1997-03-19

Family

ID=10806833

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9701919.4A Pending GB9701919D0 (en) 1996-03-08 1997-01-30 Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1

Country Status (2)

Country Link
GB (1) GB9701919D0 (en)
WO (1) WO1998033938A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014080323A1 (en) * 2012-11-26 2014-05-30 Koninklijke Philips N.V. Diagnostic genetic analysis using variant-disease association with patient-specific relevance assessment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5168043A (en) * 1986-01-10 1992-12-01 Sloan-Kettering Institute For Cancer Research Blood group antigen panel

Also Published As

Publication number Publication date
WO1998033938A1 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
CY2007001I2 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
DE69805438D1 (en) MIXING AND CHARGING OPENING FOR MEDICAL TREATMENT
DE69529307T2 (en) Ultrasound diagnosis and treatment system
DE69830728D1 (en) MEDICAMENT FOR THE TREATMENT OF COMMON WATER AND HARN INCONTINENCE
HUP0003852A3 (en) Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
EP0506893A4 (en) Diagnosis and treatment of diseases
FI965204A (en) Medical use of bromelain
EP0584340A4 (en) Diagnosis and treatment of various neuralgias
HK1046428A1 (en) The genome of the hiv-1 inter-subtype (c/b') and use thereof
EP0888381A4 (en) Targeted therapeutic or diagnostic agents and methods of making and using same
FI963638A (en) Procedures for the diagnosis and treatment of HIV-1 infection
GB9701919D0 (en) Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1
FI963263A0 (en) Medical use of bromelain
GB9908059D0 (en) Diagnosis and treatment of diseases
ZA9610584B (en) Use of rc-9 in diagnosis and treatment of proliferative arterial disease
GB9604985D0 (en) Materials and methods relating to the diagnosis of susceptibility to and the prophylactic and therapeutic treatment of certain diseases
GB9621866D0 (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of hepatitis B virus infection and leprosy
GB9700667D0 (en) Materials and methods relating to the treatment of biofilms
GB0113011D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB0205963D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9824091D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9906217D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9917878D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9621995D0 (en) Susceptibility to cancer:diagnosis and treatment thereof